Home › NDC Lookup › Ingredients › Quetiapine Fumarate › 87002-0003-00
⚪image loading
(from DailyMed)

Quetiapine Fumarate 200 mg Tablet, Film Coated — NDC 87002-003-00 (Billing 87002-0003-00)

by Klocke Pharma-Service GmbH · 2 BAG in 1 BOX / 9756 TABLET, FILM COATED in 1 BAG

This is a package of Quetiapine Fumarate 200 mg Tablet, Film Coated from Klocke Pharma-Service GmbH, marketed since Mar 2026 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 87002-0003-00
🏷️ FDA NDC (as labeled) 87002-003-00 billing pads the product segment with a zero
This package
Contains9756 tablet, film coated in 1 bag Pack sizes2 compare ↓
Main listing for product 87002-003 · Also comes in: 19512 tablets 87002-003-01
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87002-003-00 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
87002 labeler · 003 product · 00 package
Package marketed since
Mar 16, 2026
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8700200300 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87002-003-00
Product NDC 87002-003
11-digit billing NDC 87002000300
SPL Set ID 4f915bbd-f240-9b45-e063-6294a90a6285
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-03-16
Dosage form TABLET, FILM COATED
Substance QUETIAPINE FUMARATE
Why two NDCs? The FDA registers this code as 87002-003-00 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87002-0003-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats schizophrenia and bipolar disorder, including manic and depressive episodes. Extended-release versions can also be added to an antidepressant for major depressive disorde...
  • Regular tablets can be taken with or without food. Extended-release tablets are taken once daily, usually in the evening, without food or with a light meal, and must be swallowed w...
  • Sleepiness, dry mouth, dizziness, constipation, increased appetite and weight gain are the most common. Many people notice these early on. Tell your doctor if they bother you.
  • Call right away for suicidal thoughts, worsening mood, fever with stiff muscles and confusion, uncontrolled movements, fainting, seizures, signs of infection, or high blood sugar s...
📖 Read our full Quetiapine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 19512 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87002-0003-00 You're viewing this Main listing 2 BAG in 1 BOX / 9756 TABLET, FILM COATED in 1 BAG — — Active
87002-0003-01 87002-003-01 2 BAG in 1 BOX / 19512 TABLET, FILM COATED in 1 BAG — — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 2 bag in 1 box / 9756 tablet, film coated in 1 bag.
What NDC number is used to bill for this package of Quetiapine Fumarate 200 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Quetiapine fumarate 200 mg 47335-0905-18 Sun 1000 tablets $0.087 — FDA listed —
Quetiapine Fumarate 200 mg 16571-0720-01 Rising 100 tablets $0.090 AB Availability likely —
Quetiapine Fumarate 200 mg 16714-0378-01 NorthStar 100 tablets $0.090 AB Availability likely —
Quetiapine Fumarate 200 mg 65862-0493-01 Aurobindo 100 tablets $0.090 — Availability likely —
Quetiapine Fumarate 200 mg 31722-0767-01 Camber 100 tablets $0.090 AB Availability likely —
Quetiapine fumarate 200 mg 68180-0448-01 Lupin 100 tablets $0.090 AB Availability likely —
Quetiapine fumarate 200 mg 82009-0098-01 Quallent 100 tablets $0.090 AB Availability likely —
Quetiapine Fumarate 200 mg 29300-0150-01 Unichem 100 tablets $0.090 AB Availability likely —
Quetiapine Fumarate 200 mg 50268-0633-15 AvPAK 50 tablets $0.090 AB Availability likely —
Quetiapine Fumarate 200 mg 00054-0222-25 Hikma 100 tablets $0.103 AB FDA listed —
Quetiapine fumarate 200 mg 33342-0103-11 Macleods 100 tablets $0.115 AB FDA listed —
Quetiapine Fumarate 200 mg 71610-0128-15 Aphena 15 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 46708-0137-10 Alembic 100 tablets — — FDA listed —
Quetiapine Fumarate 200 mg 72865-0267-01 XLCare 100 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 68788-8859-01 Preferred 100 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 72189-0465-30 Direct_Rx 30 tablets — AB FDA listed —
Quetiapine fumarate 200 mg 16364-0148-21 Intas 4000 tablets — — FDA listed —
Quetiapine fumarate 200 mg 59765-0148-21 Intas 4000 tablets — — FDA listed —
Quetiapine Fumarate 200 mg 71335-1519-01 Bryant 30 tablets — AB Discontinued —
Quetiapine Fumarate 200 mg 51407-0069-01 Golden 100 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 63629-4964-01 Bryant 30 tablets — AB FDA listed —
Quetiapine fumarate 200 mg 71335-1362-01 Bryant 30 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 00615-8473-39 NCS 30 tablets — AB FDA listed —
Quetiapine Fumarate 200 mgthis 87002-0003-00 Klocke 9756 tablets — — FDA listed —
Quetiapine fumarate 200 mg 68788-8746-01 Preferred 100 tablets — AB FDA listed —
Quetiapine fumarate 200 mg 71335-2157-01 Bryant 30 tablets — — FDA listed —
Quetiapine Fumarate 200 mg 71335-9623-01 Bryant 30 tablets — AB FDA listed —
Quetiapine fumarate 200 mg 60760-0763-30 St. 30 tablets — AB FDA listed —
Quetiapine fumarate 200 mg 70518-1918-01 REMEDYREPACK 30 tablets — AB FDA listed —
Quetiapine Fumarate 200 mg 70518-3581-00 REMEDYREPACK 30 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Mar 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Quetiapine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerKlocke Pharma-Service GmbH
Labeler code87002
First marketedMar 2026
Product typeDrug For Further Processing
Portfolio6 products on file

More NDCs from Klocke Pharma-Service GmbH labeler code 87002

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Quetiapine Fumarate (matched by generic name) — the program that covers self-administered drugs. 15 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Quetiapine Fumarate. CMS lists 4 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$46.34M
Claims incl. refills
2.4M
Beneficiaries
1M
Spend / beneficiary
$45.82
Spend / claim
$19.65
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Klocke Pharma-Service GmbH supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Klocke Pharma-Service GmbH. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 19512 tablets (87002-0003-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Klocke Pharma-Service GmbH is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87002-0002-00 · Klocke 87002-0004-00 · Klocke →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.